
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $681M | $863.4M | $1.2B | $1.6B | $2.1B | |
Revenue Growth (YoY) | 28.28% | 26.78% | 37.5% | 31.47% | 33.44% | |
Cost of Revenues | $264.7M | $322.5M | $461M | $605.2M | $841.1M | |
Gross Profit | $416.3M | $540.9M | $726.1M | $955.5M | $1.2B | |
Gross Profit Margin | 61.14% | 62.65% | 61.17% | 61.22% | 59.61% | |
R&D Expenses | $123.2M | $194M | $233.8M | $303.7M | $441.6M | |
Selling, General & Admin | $307.3M | $515M | $399.3M | $494.9M | $741.2M | |
Other Inc / (Exp) | -- | $25.3M | $99M | -$41.9M | $286.4M | |
Operating Expenses | $430.5M | $709M | $633.1M | $798.6M | $1.2B | |
Operating Income | -$14.2M | -$168.1M | $93M | $156.9M | $58.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$6.3M | -$141.4M | $196.2M | $157.1M | $381.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$4.6M | -$81.4M | $49.3M | -$18.7M | $4.5M | |
Net Income to Company | -$1.7M | -$60M | $146.9M | $175.8M | $377M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.7M | -$60M | $146.9M | $175.8M | $377M | |
Basic EPS (Cont. Ops) | -$0.03 | -$0.91 | $2.07 | $2.37 | $4.98 | |
Diluted EPS (Cont. Ops) | -$0.03 | -$0.91 | $2.03 | $2.33 | $4.80 | |
Weighted Average Basic Share | $61.8M | $66.2M | $71.1M | $74.2M | $75.7M | |
Weighted Average Diluted Share | $61.8M | $66.2M | $72.5M | $75.5M | $78.6M | |
EBITDA | -$1.7M | -$149.4M | $116.1M | $183.4M | $437M | |
EBIT | -$14.2M | -$168.1M | $93M | $164.1M | $388.6M | |
Revenue (Reported) | $681M | $863.4M | $1.2B | $1.6B | $2.1B | |
Operating Income (Reported) | -$14.2M | -$168.1M | $93M | $156.9M | $58.5M | |
Operating Income (Adjusted) | -$14.2M | -$168.1M | $93M | $164.1M | $388.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $195M | $256.4M | $343M | $459.9M | $603.6M | |
Revenue Growth (YoY) | 32.52% | 31.49% | 33.78% | 34.06% | 31.26% | |
Cost of Revenues | $71.7M | $100.7M | $138.9M | $201.2M | $237.9M | |
Gross Profit | $123.4M | $155.7M | $204.1M | $258.6M | $365.7M | |
Gross Profit Margin | 63.25% | 60.74% | 59.5% | 56.24% | 60.59% | |
R&D Expenses | $47M | $48.4M | $70.9M | $91.1M | $151M | |
Selling, General & Admin | $126.6M | $90.1M | $116.6M | $151.1M | $223.5M | |
Other Inc / (Exp) | -- | -- | $15.6M | $139.1M | $114.4M | |
Operating Expenses | $173.6M | $138.5M | $187.5M | $242.2M | $374.5M | |
Operating Income | -$50.3M | $17.2M | $16.6M | $16.5M | -$8.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$49.7M | $72.5M | $41.9M | $165.9M | $108.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.8M | $17.6M | -$3.3M | $32.5M | $20.4M | |
Net Income to Company | -$47.9M | $54.9M | $45.1M | $133.4M | $88M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$47.9M | $54.9M | $45.1M | $133.4M | $88M | |
Basic EPS (Cont. Ops) | -$0.75 | $0.77 | $0.62 | $1.77 | $1.14 | |
Diluted EPS (Cont. Ops) | -$0.75 | $0.76 | $0.61 | $1.73 | $1.08 | |
Weighted Average Basic Share | $64M | $71M | $72.6M | $75.4M | $76.9M | |
Weighted Average Diluted Share | $64M | $72.3M | $73.9M | $77.1M | $81.5M | |
EBITDA | -$46M | $22.9M | $50.3M | $175M | $135.7M | |
EBIT | -$50.3M | $17.2M | $43.6M | $167.7M | $116.2M | |
Revenue (Reported) | $195M | $256.4M | $343M | $459.9M | $603.6M | |
Operating Income (Reported) | -$50.3M | $17.2M | $16.6M | $16.5M | -$8.8M | |
Operating Income (Adjusted) | -$50.3M | $17.2M | $43.6M | $167.7M | $116.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $728.9M | $924.8M | $1.3B | $1.7B | $2.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $277.8M | $351.5M | $499.3M | $666.7M | $881.1M | |
Gross Profit | $451.1M | $573.3M | $774.5M | $1B | $1.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $143.8M | $195.4M | $256.3M | $323.9M | $501.5M | |
Selling, General & Admin | $370.9M | $478.5M | $425.8M | $530.6M | $812.1M | |
Other Inc / (Exp) | -- | -- | $15.6M | $81.6M | $261.7M | |
Operating Expenses | $514.7M | $674M | $682.1M | $854.5M | $1.3B | |
Operating Income | -$63.6M | -$100.7M | $92.4M | $156.9M | $32.4M | |
Net Interest Expenses | -- | -- | $41.3M | -- | -- | |
EBT. Incl. Unusual Items | -$56.1M | -$19.2M | $165.6M | $281.3M | $323.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.4M | -$62M | $28.4M | $17.1M | -$7.9M | |
Net Income to Company | -$53.7M | $42.8M | $137.2M | $264M | $331.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$53.7M | $42.8M | $137.2M | $264.1M | $331M | |
Basic EPS (Cont. Ops) | -$0.86 | $0.59 | $1.92 | $3.52 | $4.34 | |
Diluted EPS (Cont. Ops) | -$0.87 | $0.52 | $1.89 | $3.45 | $4.14 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$49.7M | -$80.5M | $143.4M | $309.6M | $396.8M | |
EBIT | -$63.6M | -$100.7M | $119.4M | $288.3M | $336.3M | |
Revenue (Reported) | $728.9M | $924.8M | $1.3B | $1.7B | $2.2B | |
Operating Income (Reported) | -$63.6M | -$100.7M | $92.4M | $156.9M | $32.4M | |
Operating Income (Adjusted) | -$63.6M | -$100.7M | $119.4M | $288.3M | $336.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $195M | $256.4M | $343M | $459.9M | $603.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $71.7M | $100.7M | $138.9M | $201.2M | $237.9M | |
Gross Profit | $123.4M | $155.7M | $204.1M | $258.6M | $365.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $47M | $48.4M | $70.9M | $91.1M | $151M | |
Selling, General & Admin | $126.6M | $90.1M | $116.6M | $151.1M | $223.5M | |
Other Inc / (Exp) | -- | -- | $15.6M | $139.1M | $114.4M | |
Operating Expenses | $173.6M | $138.5M | $187.5M | $242.2M | $374.5M | |
Operating Income | -$50.3M | $17.2M | $16.6M | $16.5M | -$8.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$49.7M | $72.5M | $41.9M | $165.9M | $108.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.8M | $17.6M | -$3.3M | $32.5M | $20.4M | |
Net Income to Company | -$47.9M | $54.9M | $45.1M | $133.4M | $88M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$47.9M | $54.9M | $45.1M | $133.4M | $88M | |
Basic EPS (Cont. Ops) | -$0.75 | $0.77 | $0.62 | $1.77 | $1.14 | |
Diluted EPS (Cont. Ops) | -$0.75 | $0.76 | $0.61 | $1.73 | $1.08 | |
Weighted Average Basic Share | $64M | $71M | $72.6M | $75.4M | $76.9M | |
Weighted Average Diluted Share | $64M | $72.3M | $73.9M | $77.1M | $81.5M | |
EBITDA | -$46M | $22.9M | $50.3M | $175M | $135.7M | |
EBIT | -$50.3M | $17.2M | $43.6M | $167.7M | $116.2M | |
Revenue (Reported) | $195M | $256.4M | $343M | $459.9M | $603.6M | |
Operating Income (Reported) | -$50.3M | $17.2M | $16.6M | $16.5M | -$8.8M | |
Operating Income (Adjusted) | -$50.3M | $17.2M | $43.6M | $167.7M | $116.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $155.4M | $356.3M | $353.7M | $598.5M | $454.8M | |
Short Term Investments | $406.5M | $86.7M | $621M | $722M | $531.5M | |
Accounts Receivable, Net | $229.2M | $320.8M | $358.2M | $413M | $547.6M | |
Inventory | $90M | $108.7M | $202.5M | $269.9M | $265.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $36.9M | $56.5M | $73M | $103.1M | $130.3M | |
Total Current Assets | $982M | $1.1B | $1.8B | $2.4B | $2.3B | |
Property Plant And Equipment | $127.8M | $161.7M | $208.2M | $236.7M | $291.9M | |
Long-Term Investments | $102.4M | $114.8M | $452.8M | $231.7M | $332.6M | |
Goodwill | $25.2M | $43.6M | $45M | $57.9M | $756.8M | |
Other Intangibles | $9.4M | $15.5M | $12.2M | $19.5M | $175.2M | |
Other Long-Term Assets | $13.4M | $17M | $13.5M | $19.2M | $22.7M | |
Total Assets | $1.4B | $1.7B | $2.9B | $3.4B | $4.5B | |
Accounts Payable | $24.1M | $32.2M | $59.9M | $65.9M | $72M | |
Accrued Expenses | $56M | $100M | $142.4M | $72.9M | $103.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $680.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $5.4M | $6.5M | $6.4M | $9.8M | $12.9M | |
Total Current Liabilities | $256.3M | $418.5M | $602.6M | $761.5M | $1.7B | |
Long-Term Debt | -- | -- | $674M | $677.1M | $680.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $404.8M | $640.4M | $1.6B | $1.8B | $2.1B | |
Common Stock | $1K | $1K | $1K | $1K | $1K | |
Other Common Equity Adj | $141K | -$1.3M | -$7.2M | -$10.7M | -$18.2M | |
Common Equity | $976.3M | $1B | $1.3B | $1.6B | $2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $976.3M | $1B | $1.3B | $1.6B | $2.3B | |
Total Liabilities and Equity | $1.4B | $1.7B | $2.9B | $3.4B | $4.5B | |
Cash and Short Terms | $562M | $443M | $974.7M | $1.3B | $986.3M | |
Total Debt | -- | -- | $674M | $677.1M | $680.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $154.8M | $386.4M | $263.4M | $403.9M | $1.1B | |
Short Term Investments | $440.8M | $77.6M | $829.9M | $659.9M | $1.3B | |
Accounts Receivable, Net | $185.4M | $344.9M | $379.9M | $476.8M | $600.4M | |
Inventory | $89.7M | $122.2M | $220.3M | $271.3M | $279.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $43.1M | $67.2M | $142.3M | $123.7M | $155.8M | |
Total Current Assets | $986.2M | $1.1B | $2.1B | $2.2B | $3.8B | |
Property Plant And Equipment | $135.3M | $172.7M | $172.7M | $209.2M | $259.9M | |
Long-Term Investments | $108M | $172.2M | $308.8M | $280.1M | $413.7M | |
Goodwill | $25.2M | $43.6M | $45M | $308.5M | $755.9M | |
Other Intangibles | $8.6M | $14.4M | $11.3M | $89.4M | $168.8M | |
Other Long-Term Assets | $15.7M | $16M | $168.2M | $212.5M | $235.7M | |
Total Assets | $1.4B | $1.8B | $3B | $3.6B | $6.1B | |
Accounts Payable | $19.8M | $49.3M | $66M | $82.1M | $97.7M | |
Accrued Expenses | $38.6M | $65.8M | $113.1M | $127.4M | $128.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $278.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $5.7M | $6.9M | $7.5M | $9.6M | $10.7M | |
Total Current Liabilities | $239.8M | $470.7M | $616.1M | $757.5M | $1.3B | |
Long-Term Debt | -- | -- | $674.7M | $677.9M | $1.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $394M | $647.7M | $1.6B | $1.8B | $3.5B | |
Common Stock | $1K | $1K | $1K | $1K | $1K | |
Other Common Equity Adj | $142K | -$2.9M | -$5.3M | -$11.6M | -$18M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1B | $1.1B | $1.4B | $1.8B | $2.6B | |
Total Liabilities and Equity | $1.4B | $1.8B | $3B | $3.6B | $6.1B | |
Cash and Short Terms | $595.7M | $464M | $1.1B | $1.1B | $2.4B | |
Total Debt | -- | -- | $674.7M | $677.9M | $2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.7M | -$60M | $146.9M | $175.8M | $377M | |
Depreciation & Amoritzation | $12.5M | $18.7M | $23.1M | $19.3M | $48.4M | |
Stock-Based Compensation | $133.6M | $303.3M | $106.2M | $131.4M | $382.6M | |
Change in Accounts Receivable | -$107.8M | -$205.8M | -$78.2M | -$179M | -$245.8M | |
Change in Inventories | -$52.2M | -$18.3M | -$95M | -$77.6M | $607K | |
Cash From Operations | $38.5M | $124.5M | $235.4M | $189.3M | $408.3M | |
Capital Expenditures | $72.9M | $50.3M | $55.8M | $59.6M | $78.8M | |
Cash Acquisitions | -- | -$22.4M | -$2.1M | -$21.1M | -$621.8M | |
Cash From Investing | -$356.5M | $252.6M | -$831M | $12.5M | -$490.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $673.8M | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -$74K | -- | -- | |
Other Financing Activities | -$7.8M | -$331.3M | -$199.9M | -$107.9M | -$60M | |
Cash From Financing | $299.3M | -$174.2M | $598.1M | $41.3M | -$45.4M | |
Beginning Cash (CF) | $172.4M | $155.6M | $356.4M | $355.6M | $600.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$18.8M | $202.9M | $2.5M | $243.1M | -$127.7M | |
Ending Cash (CF) | $155.6M | $356.4M | $355.6M | $600.7M | $466.8M | |
Levered Free Cash Flow | -$34.4M | $74.2M | $179.6M | $129.6M | $329.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$47.9M | $54.9M | $45.1M | $133.4M | $88M | |
Depreciation & Amoritzation | $4.3M | $5.8M | $6.7M | $7.4M | $19.5M | |
Stock-Based Compensation | $89.6M | $25.1M | $34.4M | $75.1M | $140.2M | |
Change in Accounts Receivable | $31.3M | $7.5M | -$50.4M | -$56.7M | -$73.6M | |
Change in Inventories | $520K | -$14.3M | -$15.8M | -$2.1M | -$17M | |
Cash From Operations | $60.9M | $44M | -$56.3M | -$15.9M | $25.8M | |
Capital Expenditures | $10.6M | $17.1M | $8.6M | $16.2M | $24.9M | |
Cash Acquisitions | -- | -- | -- | -$237.8M | -- | |
Cash From Investing | -$54.1M | -$10.3M | -$72.7M | -$174M | -$702.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $1.8B | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$431.7M | |
Repurchase of Common Stock | -- | -$71K | -- | -- | -- | |
Other Financing Activities | -$7M | -$1.4M | -$34.8M | -$2.7M | -$5.1M | |
Cash From Financing | -$7M | -$1.5M | $38M | -$2.7M | $1.3B | |
Beginning Cash (CF) | $155.6M | $356.4M | $355.6M | $600.7M | $466.8M | |
Foreign Exchange Rate Adjustment | -$392K | -$157K | $779K | -$2M | $1.2M | |
Additions / Reductions | -$229K | $32.2M | -$91M | -$192.7M | $636.8M | |
Ending Cash (CF) | $154.9M | $388.4M | $265.3M | $406M | $1.1B | |
Levered Free Cash Flow | $50.4M | $26.8M | -$65M | -$32.1M | $932K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$53.7M | $42.8M | $137.2M | $264M | $331.7M | |
Depreciation & Amoritzation | $13.9M | $20.2M | $24.1M | $20M | $60.5M | |
Stock-Based Compensation | $203M | $238.8M | $115.4M | $172.1M | $447.7M | |
Change in Accounts Receivable | -$66.8M | -$229.6M | -$136.2M | -$185.3M | -$262.7M | |
Change in Inventories | -$43M | -$33.1M | -$96.6M | -$63.9M | -$14.3M | |
Cash From Operations | $86M | $107.5M | $135.1M | $229.6M | $450M | |
Capital Expenditures | $81.2M | $56.9M | $47.3M | $67.2M | $87.5M | |
Cash Acquisitions | $4.7M | -$22.4M | -$2.1M | -$258.9M | -$384M | |
Cash From Investing | -$388.6M | $296.3M | -$893.3M | -$88.9M | -$1B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9.7M | -$325.7M | -$233.3M | -$75.8M | -$62.4M | |
Cash From Financing | $297.4M | -$168.6M | $637.5M | $614K | $1.3B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.2M | $235.3M | -$120.7M | $141.4M | $701.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $4.8M | $50.7M | $87.8M | $162.5M | $362.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$47.9M | $54.9M | $45.1M | $133.4M | $88M | |
Depreciation & Amoritzation | $4.3M | $5.8M | $6.7M | $7.4M | $19.5M | |
Stock-Based Compensation | $89.6M | $25.1M | $34.4M | $75.1M | $140.2M | |
Change in Accounts Receivable | $31.3M | $7.5M | -$50.4M | -$56.7M | -$73.6M | |
Change in Inventories | $520K | -$14.3M | -$15.8M | -$2.1M | -$17M | |
Cash From Operations | $60.9M | $44M | -$56.3M | -$15.9M | $25.8M | |
Capital Expenditures | $10.6M | $17.1M | $8.6M | $16.2M | $24.9M | |
Cash Acquisitions | -- | -- | -- | -$237.8M | -- | |
Cash From Investing | -$54.1M | -$10.3M | -$72.7M | -$174M | -$702.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $1.8B | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$431.7M | |
Repurchase of Common Stock | -- | -$71K | -- | -- | -- | |
Other Financing Activities | -$7M | -$1.4M | -$34.8M | -$2.7M | -$5.1M | |
Cash From Financing | -$7M | -$1.5M | $38M | -$2.7M | $1.3B | |
Beginning Cash (CF) | $155.6M | $356.4M | $355.6M | $600.7M | $466.8M | |
Foreign Exchange Rate Adjustment | -$392K | -$157K | $779K | -$2M | $1.2M | |
Additions / Reductions | -$229K | $32.2M | -$91M | -$192.7M | $636.8M | |
Ending Cash (CF) | $154.9M | $388.4M | $265.3M | $406M | $1.1B | |
Levered Free Cash Flow | $50.4M | $26.8M | -$65M | -$32.1M | $932K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.